Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Biomarker Research|October 18, 2014
Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemiaKerstin Willander, Ingrid Jakobsen Falk, Roza Chaireti, et al.
Oncotarget|September 13, 2014
Mapping of apoptin-interaction with BCR-ABL1, and development of apoptin-based targeted therapyJaganmohan R Jangamreddy, Soumya Panigrahi, Kourosh Lotfi, et al.
European Journal of Haematology|August 27, 2014
TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcomeIngrid Jakobsen Falk, Kerstin Willander, Roza Chaireti, et al.
Biomolecules|September 28, 2021
Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome SystemKarthik Selvaraju, Kourosh Lotfi, Johannes Gubat, et al.
Oncotarget|August 24, 2015
Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosisMohamed Ali Mosrati, Kerstin Willander, Ingrid Jakobsen Falk, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2018
Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class CBjörn Ingelsson, Daniel Söderberg, Tobias Strid, et al.
British Journal of Haematology|August 19, 2011
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in miceAmanda Nordigården, Jenny Zetterblad, Cecilia Trinks, et al.
British Journal of Haematology|August 27, 2014
Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotypeIngrid Jakobsen Falk, Anna Fyrberg, Esbjörn Paul, et al.
American Journal of Hematology|July 23, 2013
Decreased survival in normal karyotype AML with single-nucleotide polymorphisms in genes encoding the AraC metabolizing enzymes cytidine deaminase and 5'-nucleotidaseIngrid Jakobsen Falk, Anna Fyrberg, Esbjörn Paul, et al.
Oncoimmunology|August 18, 2022
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factorsDorina Ujvari, Alena Malyukova, Ana Zovko, et al.
Pageof 5